Ownership history in Kynam Capital Management, LP · 16 quarters on record
This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in COGENT BIOSCIENCES INC (COGT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 6,165,223 | -1,720,949 | -21.8% | 13.99% | $219.0M | $35.52 |
| 2025 Q3 | REDUCED | 7,886,172 | -606,385 | -7.1% | 8.43% | $113.2M | $14.36 |
| 2025 Q2 | REDUCED | 8,492,557 | -612,443 | -6.7% | 6.56% | $61.0M | $7.18 |
| 2025 Q1 | UNCHANGED | 9,105,000 | — | 0% | 4.58% | $54.5M | $5.99 |
| 2024 Q4 | REDUCED | 9,105,000 | -134,731 | -1.5% | 4.20% | $71.0M | $7.80 |
| 2024 Q3 | REDUCED | 9,239,731 | -20,654 | -0.2% | 7.65% | $99.8M | $10.80 |
| 2024 Q2 | ADDED | 9,260,385 | +760,385 | +8.9% | 6.02% | $78.1M | $8.43 |
| 2024 Q1 | ADDED | 8,500,000 | +2,645,234 | +45.2% | 5.98% | $57.1M | $6.72 |
| 2023 Q4 | ADDED | 5,854,766 | +3,644,641 | +164.9% | 3.81% | $34.4M | $5.88 |
| 2023 Q3 | ADDED | 2,210,125 | +592,734 | +36.6% | 3.52% | $21.5M | $9.75 |
As of 2025 Q4 — sorted by position size